CLASS II Device recall · Reported 24 Apr 2013 · FDA Enforcement Report

Duraflo coated Femoral Cannula recalled by Edwards Lifesciences

Edwards Lifesciences is recalling Duraflo coated Femoral Cannula, distributed nationwide in the US. The recall was initiated on 14 Mar 2013 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesModel DIIFEMII018A, Lot 59337174
Quantity recalled379 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1111-2013
FDA event ID
64782
Recalling firm
Edwards Lifesciences, Draper, UT
Classification
Class II
Status
Terminated
Recall initiated
14 Mar 2013
FDA classified
14 Apr 2013
Reported
24 Apr 2013
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Sterility

Timeline

14 Mar 2013Recall initiated by company
14 Apr 2013Classified by FDA+31 days
24 Apr 2013Published in enforcement report+10 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Two unsealed pouches were found at an Edwards' distribution location in Japan. Incorrectly sealed pouches may result in a sterility barrier breach.

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

Edwards Lifesciences Duraflo coated Femoral Cannula. Product Usage: The cannulae are intended for use in situations which require rapid femoral venous and arterial access for short-term (< 6 hours) cardiopulmonary bypass. Vessel access (venous or arterial) is left to the discretion of the physician. Extracorporeal circuit components with a Duraflo coating are intended for use in cardiopulmonary surgery when a heparin-coated blood path is desired. The femoral arterial cannulae are wire-reinforced, thin-wall cannulae.

Where it was distributed

USA Nationwide Distribution including the states of: FL, MA, MI, NY, PA, TX.

Nationwide FloridaMassachusettsMichiganNew YorkPennsylvaniaTexas

Questions about this recall

Why was it recalled?

Two unsealed pouches were found at an Edwards' distribution location in Japan. Incorrectly sealed pouches may result in a sterility barrier breach.

Which lots are affected?

Model DIIFEMII018A, Lot 59337174

Where was it sold?

USA Nationwide Distribution including the states of: FL, MA, MI, NY, PA, TX.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Edwards Lifesciences

All 95

Other Heart & Vascular Devices recalls

All 6,199